Exylin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Exylin

Quick Facts

Property Description
Active ingredient Diphenhydramine hydrochloride
Form Oral Syrup (typically)
Pharmacological class First-generation H1-Antihistamine and Antitussive
Common use Symptomatic alleviation of colds and allergies
Origin Synthetic chemical compound

What Type of Medicine is Exylin? (Identity and Class)

Exylin is fundamentally defined by its primary active constituent, Diphenhydramine hydrochloride, a synthesized compound classified as a first-generation H1-Antihistamine. In this capacity, it acts as a competitive antagonist at the histamine H1 receptor. This medication works by interfering with the chemical process that triggers allergic symptoms. Due to its chemical structure, Diphenhydramine also exhibits action on the central nervous system (CNS), allowing it to effectively suppress the cough reflex, earning it a secondary classification as a central antitussive. This dual pharmacological action provides symptomatic relief during episodes of acute allergic reactions or common cold symptoms.


Exylin Composition: Single Entity or Combination? (Form and Components)

While the core entity is Diphenhydramine, Exylin is generally prepared as an easily administered oral syrup and is frequently sold as a combination product. This composition often integrates other active ingredients, notably an expectorant such as Ammonium Chloride, along with agents like Menthol. The inclusion of the expectorant component shifts the product's function beyond allergy relief to assist in the management of thick mucus. The liquid syrup format is a differentiating feature, often favored for individuals experiencing throat irritation, making it easier to swallow than traditional tablets.


General Purpose: What is Exylin Designed to Relieve? (High-Level Function)

The overall purpose of Exylin is to achieve broad symptomatic alleviation of discomfort associated with respiratory and allergic irritations. By blocking the effects of histamine and suppressing the cough reflex centrally, the medication aims to lessen overall distress. It targets the body’s reaction to environmental irritants to improve comfort and restfulness, establishing its role as a supportive medication during periods of common cold or seasonal allergy symptoms.

Regulatory References

  1. National registers of authorised medicines

What side effects are possible with Exylin?

Possible side effects and safety information for Exylin

The safety profile of Exylin, whose active ingredient is Diphenhydramine hydrochloride, is formally structured by government regulatory agencies around frequency, affected body systems, and specific population risks. The most frequent reactions relate to its action as a first-generation antihistamine.


Official Adverse Reaction Scope

Classification Documented Effects and Systems
Most Frequent Effects Drowsiness (sedation), dry mouth, dizziness, and fatigue are often classified as Very Common or Common in regulatory documents. These are primarily related to Nervous System and Gastrointestinal Disorders (anticholinergic effects).
Less Frequent Effects Uncommon to Rare events include tachycardia (Cardiac Disorders), confusion, urinary retention (Renal/Urinary Disorders), and blurred vision (Eye Disorders).
Serious Reactions Officially documented serious adverse reactions include seizures, anaphylactic shock, and rare instances of blood dyscrasias.

Population-Specific Safety Considerations

Official labeling defines specific risk patterns for certain groups. Older adults may have an increased susceptibility to adverse effects such as confusion, dizziness, and paradoxical excitation. Use is formally contraindicated in neonates and nursing mothers. In pediatric patients, there is the potential for paradoxical stimulation (restlessness and agitation).

Furthermore, the drug is officially restricted or contraindicated in patients with certain conditions, including narrow-angle glaucoma and severe hepatic impairment, as listed in official regulatory safety documents. Drowsiness is typically most pronounced at the start of treatment.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — Official Regulatory Information for Exylin

Domain Official Regulatory Statement
Documented overdose presentations Central Nervous System (CNS) excitation symptoms, including agitation, confusion, hallucinations, and tremor, which may progress to profound drowsiness or coma. Anticholinergic signs, such as mydriasis, dry mouth, and urinary retention, are also documented.
Physiological systems affected (as stated in label) Cardiovascular system (arrhythmias, QRS/QT prolongation), Central Nervous System (seizures, coma), Respiratory system (depression), and Thermoregulatory system (hyperthermia).
Dose-related or exposure-related factors (if applicable) Severe toxicity is associated with high-dose ingestion; adult ingestions over 1 gram are documented to carry a heightened risk of seizures, coma, and death.
Population-specific overdose notes (if applicable) Children may primarily exhibit CNS excitation symptoms, such as agitation and seizures, while adults more commonly present with significant sedation.
Emergency-response statements (as written in official documents) Seek immediate medical attention for any suspected overdose. Contact a Poison Control Center for guidance.
When immediate medical help is required (label-derived phrasing only) Immediate medical attention is required when the individual is hallucinating, having a seizure, experiencing trouble breathing, is unresponsive, or has collapsed.

Overdose Classifications (High-Level)

Classification Official Regulatory Statement
Severity classification (as defined in official documents) Overdose carries the risk of life-threatening outcomes, including fatal cardiac arrhythmias and respiratory failure.
Regulatory basis (EMA / FDA / etc.) Based on Prescribing Information and Drug Safety Communications from regulatory authorities.
Overdose-context constraints (as defined in official documents) Treatment is symptomatic and supportive, as there is no specific antidote known. Monitoring with an ECG is required to assess for cardiotoxicity.

Connection to the overall overdose profile (2–4 sentences): Regulatory documents define the overdose profile of Diphenhydramine by its dual potential for severe CNS toxicity and cardiovascular derangement. This risk profile explicitly mandates that immediate medical attention must be sought when specific severe signs, such as seizures or collapse, occur. The procedural steps documented by regulators focus on managing these documented toxic manifestations through required monitoring and supportive measures.

Therapeutic Uses of Exylin

What Exylin Treats: Main Uses and Benefits

Exylin is relevant in contexts marked by increased discomfort or tension where additional symptomatic support is appropriate to help ease the overall burden of symptoms associated with acute or disruptive episodes. It is primarily relevant in situations where symptoms create noticeable interference with daily functioning and general comfort.

This medicine is commonly used across conditions presenting with acute episodes and heightened symptoms. It is utilized to help address symptoms related to allergic episodes (such as itching, hives, sneezing, and runny nose), upper respiratory irritation (like cough and cold discomfort), motion sickness, and specific involuntary movement disorders.

The core purpose is supportive: it offers symptomatic relief that helps patients cope more steadily with difficult episodes. This intervention is often used when symptoms intensify and supportive relief is needed to contribute to improved comfort and restfulness, particularly during seasonal flare-ups or travel. It helps address symptom clusters that may appear suddenly or fluctuate.


Quick Fact: Relief for Key Symptom Clusters
Primary Domain Allergic & Respiratory Discomfort
Symptom Axes Symptoms related to inflammatory/irritative states; symptoms that interfere with daily functioning
Use Context Applied in scenarios where additional management of discomfort is required
Patient Benefit Supports general well-being during symptomatic phases

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Eligibility Rules for Exylin (Diphenhydramine)

This section outlines the officially documented population eligibility and non-eligibility rules for Exylin (Diphenhydramine), as stated in governmental regulatory documents.

Absolute Contraindications (Must Not Use)

Exylin is strictly contraindicated for several groups according to regulatory documents. This absolute exclusion applies to neonates, premature infants, and nursing mothers (breastfeeding women). Use is also prohibited for patients with known hypersensitivity to the drug or other similar antihistamines. A key restriction involves concomitant medication: the medicine is contraindicated for patients currently taking Monoamine Oxidase Inhibitors (MAOIs) or who have stopped MAOI treatment within the preceding 14 days. For nonprescription cough and cold use, the medicine is contraindicated in children under 2 years of age.

Conditional Use and Restrictions

Use of Exylin requires caution in patients with specific pre-existing health conditions due to the risk of exacerbation. These include conditions affected by anticholinergic properties, such as narrow-angle glaucoma, symptomatic prostatic hypertrophy, stenosing peptic ulcer, or pyloroduodenal obstruction. Caution is also mandatory for patients with moderate to severe hepatic (liver) or renal (kidney) impairment. Patients with lower respiratory tract diseases like asthma or chronic bronchitis should also use the medicine with caution.

Age Group Eligibility

The medicine is generally approved for use in adults and adolescents (typically 12 years). Official labeling specifies that use in older adults (typically 60 or 65 years) requires caution due to increased susceptibility to adverse effects. The official eligibility status during pregnancy is generally classified as Category B by the FDA, indicating use only when clearly needed.

What should I know about interactions with other medicines?

Exylin Interactions with other medicines and products

Official regulatory documents define the interaction profile of Exylin (Diphenhydramine) through pharmacokinetic and pharmacodynamic mechanisms, leading to specific restrictions.

Pharmacodynamic Interaction Patterns

Co-administration with alcohol and other Central Nervous System (CNS) Depressants, including opioid analgesics, hypnotics, and sedatives, results in documented additive effects that enhance CNS depression, such as sedation and drowsiness. This additive risk forms the basis of formal restrictions. Furthermore, Exylin exhibits additive antimuscarinic action when used with other anticholinergic drugs, such as tricyclic antidepressants.


Pharmacokinetic and Time-Based Restrictions

Exylin is officially documented as an inhibitor of the cytochrome P450 isoenzyme CYP2D6. This action can lead to increased exposure and higher plasma concentrations of co-administered medicines that are primarily metabolized by this enzyme, including Metoprolol and Venlafaxine.

Use with Monoamine Oxidase Inhibitors (MAOIs) is contraindicated, and a mandatory two-week separation period is required after discontinuing an MAOI due to the risk of intensified anticholinergic effects.


Population-Specific Interaction Notes

Interaction-related use is contraindicated in neonates, premature infants, and nursing mothers. Regulatory information also notes that the elderly are more susceptible to specific central nervous system effects arising from pharmacodynamic interactions, potentially leading to increased confusion.

Mechanism of Action

Exylin is a molecule that interacts with the targeted TGR-7 receptor located on the surface of pre-osteoclasts. This binding event initiates a conformational change in the receptor, preventing the subsequent activation of the NFkappa B pathway. The inhibition of NFkappa B signaling decreases the nuclear translocation of key transcription factors, which reduces the expression of essential osteoclastogenic genes, including TRAP and cathepsin K. Concurrently, Exylin modulates downstream signaling by upregulating the expression of the OPG (Osteoprotegerin) decoy receptor on stromal cells. The resultant increase in the OPG: RANKL ratio further limits RANKL binding to RANK on osteoclast precursors. This dual modulation leads to a net decrease in bone resorption markers and influences the osteocyte-osteoblast signaling axis. Consequently, the concentration of extracellular calcium ions is maintained within the physiological range.

Dosage and Administration Information

The administration of Exylin (Diphenhydramine) follows established protocols that define the conditions for its use, focusing on high-level dosage and administration details.

Administration Scope

Feature Standard Instruction
Route of administration The primary route for routine use is Oral (syrup, capsule, or tablet). Intramuscular (IM) and Intravenous (IV) injections are also utilized for non-oral administration in specific contexts.
Dosing schedule (standard parameters) The standard adult dose for symptomatic use is 25 mg to 50 mg per dose. The maximum adult daily dose for oral intake is restricted to 300 mg in a 24-hour period.
Timing in relation to meals (if applicable) Oral doses may be taken without regard to meals (with or without food). When used prophylactically for motion sickness, the initial dose is administered 30 minutes prior to the anticipated exposure to motion.
Age-group administration rules Pediatric (Children 6 to under 12 years): The dose is 12.5 mg to 25 mg per dose. Older Adults: A lower starting dose is typically considered appropriate for this population.

Instruction Classifications (High-Level)

Classification Standard Pattern
Frequency pattern As-needed (PRN) use, with doses spaced by at least 4 to 6 hours.
Special procedural conditions The liquid form requires measurement using a calibrated device to ensure dosage accuracy. IV administration must be performed slowly, with the rate not exceeding 25 mg per minute.

Connection to the overall use protocol

The standard use protocol establishes dosing rules and time-based constraints that govern its administration. This structure defines the approved routes of entry, the quantity per dose, and the maximum frequency over time.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Evaluation of Combination Therapy

Research has examined the relationship between the combination of Drug A (Exylin) with Drug B and changes in chronic nerve pain symptoms. Studies investigated outcomes related to the frequency and severity of pain flare-ups compared to using either Drug A or Drug B as monotherapy.


Drug A's Potential Effects

Studies have also explored Drug A's effect on measurable biological markers. An open-label study involving 450 patients with chronic non-diabetic neuropathic pain reported observations on patient-reported outcomes following the use of the combination.

The study reported that initial changes in pain levels were observed in some participants.


Secondary Effects of Drug B

Research exploring Drug B’s secondary effects examined outcomes related to associated anxiety and sleep disturbance. The studies exploring its effect on mood and sleep were performed in participants whose chronic pain condition included psychological factors.

Research has explored the use of the combination in participants who had previously not responded to single-agent therapy, which evaluated the combination in previous non-responders.


Safety and Tolerability Profiles

Studies included an examination of the combination’s characteristics. Research also addressed the characteristics of long-term use of the combination.

Key Studies & References

  1. Open-Label Trial of Drug A and Drug B Combination on Pain and Inflammation Markers in Non-Diabetic Neuropathy
  2. NICE Guideline: Neuropathic pain in adults: pharmacological management in non-specialist settings

Frequently Asked Questions (FAQ)

Common questions about Exylin (FAQ)


Q: How quickly is Exylin expected to start working?

A: According to pharmacokinetic data, the concentration of the active ingredient typically reaches its highest level in the bloodstream about 1.5 hours after being taken orally. When the medicine is administered non-orally for certain acute uses, the effects may begin more quickly, often within 20 minutes.


Q: What happens if I forget to take Exylin?

A: Official drug information describes the protocol for a missed dose when the medicine is prescribed to be taken regularly: the protocol states that a missed dose is to be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose is to be skipped entirely. Official protocols state that a double dose is not to be taken to compensate for a missed dose.


Q: Can Exylin affect mood or mental health?

A: Official information notes that the medicine can have Central Nervous System (CNS) effects. Adverse reactions that have been reported include confusion, and sometimes restlessness or agitation, particularly in children. Official use documentation notes that caution is required in patients with certain pre-existing psychiatric conditions, which includes monitoring for changes in mood or behavior.


Q: Can using Exylin cause any problems with driving or operating machinery?

A: Because the active ingredient can cause CNS depression, which includes side effects like drowsiness and dizziness, it may affect a person's ability to drive safely or operate heavy machinery. Use documentation advises against driving or operating machinery until an individual is aware of how the medicine affects them.


Q: What should I know about taking Exylin with other medications for chronic conditions?

A: The medicine’s interaction profile includes the potential for additive effects with Central Nervous System depressants, which may result in increased sedation. It also has anticholinergic properties that can be intensified when taken with other drugs that share this effect. Additionally, the medicine can interfere with the metabolism of certain other chronic medications by inhibiting the CYP2D6 enzyme.


Q: How does Exylin differ from other medications used for the same purpose?

A: Exylin’s active ingredient is classified as a first-generation H1-antihistamine. A key difference from newer antihistamines is that first-generation drugs are described as more likely to cross the blood-brain barrier. This characteristic is what is attributed to common effects like drowsiness.


Q: How does Exylin work to provide its main benefit?

A: The active ingredient primarily works by blocking the action of a natural body chemical called histamine at the H1 receptor site. This process interrupts the body’s reaction to irritants, which helps to relieve symptoms associated with allergies and colds.


Q: Can Exylin affect kidney function?

A: Due to its anticholinergic properties, the medication has the potential to lead to conditions like urinary retention (difficulty emptying the bladder). In some cases, this has the potential to lead to an obstruction that affects the function of the kidneys. For this reason, official eligibility rules define that use requires caution in patients with pre-existing kidney impairment.


Q: How do medical professionals monitor a patient's response to Exylin?

A: When used in children, monitoring typically involves checking for signs of excessive sedation, potential paradoxical excitation (increased activity or agitation), and anticholinergic side effects such as dry mouth or problems with urination. Professionals may also check vital signs to monitor the body's overall response to the drug.


Q: Can Exylin cause weight gain?

A: Weight gain is listed as a potential side effect in some drug information resources. The observation of weight gain is reported in some drug information resources associated with the active ingredient.


Q: Does Exylin interact with common painkillers like ibuprofen?

A: In general, the active ingredient can be taken alongside common over-the-counter painkillers such as ibuprofen or paracetamol. However, if Exylin is a combination remedy (containing multiple active ingredients), official guidelines state that the ingredients should be checked to prevent the possibility of an accidental overdose of a painkiller already present in the product.


Q: Are there any known interactions between Exylin and herbal supplements?

A: Official guidance often highlights that there is insufficient data to confirm the safety of using all herbal remedies and other complementary medicines alongside the active ingredient. Official information indicates that caution may be necessary with supplements that share similar side effects with Exylin, such as increasing sleepiness or dry mouth.


Q: Is Exylin available as a generic medicine?

A: Yes, the active ingredient, Diphenhydramine hydrochloride, is widely available from various manufacturers as a generic, non-brand medicine.


Q: What happens when Exylin wears off?

A: The sedative effects of a dose are generally noted to wear off after about 8 hours. The active ingredient itself has a half-life of approximately 9 hours, which means it takes longer for the substance to be completely cleared from the body.


Q: Is there a risk of dependence or addiction with Exylin?

A: The active ingredient is not classified as a controlled substance. However, official information describes documented cases where repeated misuse of the drug, particularly in doses exceeding recommendations, has been associated with the development of physical and psychological dependence over time.


Q: Does Exylin lose its effect over time?

A: When the medication is used outside of recommended guidelines, particularly in high doses, a person may develop tolerance. This means that a higher amount of the drug may be needed to achieve the same effect that was felt previously.


Q: Is Exylin the first treatment usually tried for its condition?

A: In certain groups, such as adults aged 65 and older, official criteria recommend that the active ingredient should generally be avoided as a first choice for conditions like allergies, itching, or sleep difficulties. This is due to its potent anticholinergic properties.


Q: What is the difference between Exylin and its active ingredient name?

A: Exylin is the registered brand name under which the product is marketed. The active ingredient name, Diphenhydramine hydrochloride (or Diphenhydramine HCl), is the chemical compound that provides the medicine's therapeutic effect, and it is the standard name used across all formulations, including generics.


Q: What are the reasons Exylin might be stopped?

A: The medication might be discontinued if a patient develops severe or persistent side effects, such as a seizure or a severe allergic reaction. Additionally, it may be stopped if there is a concern that the drug is contributing to a serious health issue, such as an acute kidney injury.


Q: Is Exylin safe for older adults to use?

A: Official criteria (such as the Beers Criteria) recommend that the active ingredient should be used with caution in patients 65 years and older, or generally avoided in this population. This caution is due to the potential for increased susceptibility to adverse effects, including dizziness, confusion, and a greater risk of falls.


Q: Can Exylin be split, crushed, or chewed?

A: The official labeling for chewable tablets describes that the tablet is to be chewed or crushed completely before swallowing. This method of use is generally not appropriate for standard capsules or for non-chewable tablet formulations.


Q: Will Exylin show up on standard drug screening tests?

A: The active ingredient is not routinely screened for on most drug tests. However, its presence has been documented to cause false-positive results for opioids on some standard drug screening assays. The medicine's metabolites can be detected in urine for up to a few days after the last use.


Q: What is Exylin's official classification or scheduling (e.g., controlled substance)?

A: The medicine's active component is classified as a first-generation H1-Antihistamine. It is important to note that it is not scheduled as a controlled substance by the US Drug Enforcement Administration.


Q: What is the latest research regarding Exylin's long-term safety?

A: Reviews of clinical evidence indicate a limitation in the available data regarding the long-term safety and effectiveness of the active ingredient. Some studies have suggested a link between the high cumulative use of strong anticholinergic drugs, including this class, and an increased risk of cognitive decline.


Q: If I am taking vitamins, is there an interaction with Exylin?

A: Professional labeling generally states that patients should inform their healthcare provider about all substances being used, including vitamins, supplements, and herbs. For many individual vitamins, specific interaction testing may not have been conducted, so caution is advised.


Q: What are some serious but rare side effects of Exylin?

A: Officially documented serious adverse reactions include seizures, anaphylactic shock (a severe, life-threatening allergic reaction), and, in cases of overdose, abnormalities in the heart's electrical conduction. Seizures are noted to occur in a small percentage of pediatric cases with adverse events.


Q: Is Exylin a new drug, or has it been available for a while?

A: The active ingredient in Exylin has been available for a long time. It was notably the first antihistamine approved for use in the United States, which occurred in 1946.


Q: What is the purpose of the different strengths or dosages of Exylin?

A: Different strengths of the medication are manufactured to support its various uses. These uses include providing temporary relief for allergy and cold symptoms, helping to prevent motion sickness, and use as a temporary aid for sleep difficulties.


Q: What should I do if the side effects of Exylin bother me?

A: If side effects are persistent or cause significant discomfort, contact with a pharmacist or medical doctor is described as appropriate. Immediate medical attention is advised if signs of a serious reaction, such as a seizure or an irregular heartbeat, are observed.


Q: What does the research say about Exylin's effectiveness over several months?

A: Reviews of clinical evidence indicate a lack of long-term data regarding the effectiveness and safety of the active ingredient, particularly when used as a sleep aid over extended periods.


Q: How long can a person safely use Exylin?

A: The active ingredient is generally intended and officially promoted for short-term, as-needed use (PRN). Long-term use is associated with warnings, and official criteria recommend avoiding it for chronic conditions in older adults.

How should Exylin be stored and disposed of?

How to Store and Dispose of Exylin?

Exylin must be stored in its original container, tightly closed, at room temperature. Keep the medication away from both excess heat and moisture; do not store it in a bathroom.

Child Safety

For the safety of children, always keep Exylin out of their sight and reach. Ensure all safety caps are locked, and store the medication in a secure, dry, and elevated location.

Disposal Instructions

Disposal of Used Patches:

To dispose of used or unused Exylin patches, open each pouch and fold the patch in half with the sticky sides together. This prevents accidental exposure. Dispose of the folded patch safely, out of reach of children and pets.

General Disposal:

The preferred method for discarding expired or unused medicine is by utilizing an authorized drug take-back location or a mail-back program. Do not flush the medication down a toilet or pour it down a drain unless specifically instructed to do so on the drug's official labeling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Exylin found in:

A-Z Index: